355 related articles for article (PubMed ID: 21178976)
1. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
[TBL] [Abstract][Full Text] [Related]
2. Is ghrelin a biomarker for mortality in end-stage renal disease?
Mak RH; Cheung WW
Kidney Int; 2011 Apr; 79(7):697-9. PubMed ID: 21403653
[TBL] [Abstract][Full Text] [Related]
3. Association with Helicobacter pylori infection and ghrelin level in hemodialysis patients.
Sugimoto M; Yasuda H
Kidney Int; 2011 Oct; 80(8):894; author reply 894. PubMed ID: 21960171
[No Abstract] [Full Text] [Related]
4. Like total ghrelin, acylated ghrelin is also lower in HD patients with cardiovascular disease.
Eleftheriadis T; Antoniadi G; Liakopoulos V; Sparopoulou T; Stefanidis I; Galaktidou G
Kidney Int; 2011 Oct; 80(7):783; author reply 783-4. PubMed ID: 21918561
[No Abstract] [Full Text] [Related]
5. Is a body mass index of 23 kg/m² a reliable marker of protein-energy wasting in hemodialysis patients?
Leal VO; Moraes C; Stockler-Pinto MB; Lobo JC; Farage NE; Velarde LG; Fouque D; Mafra D
Nutrition; 2012 Oct; 28(10):973-7. PubMed ID: 22503532
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
[TBL] [Abstract][Full Text] [Related]
8. Interaction between geriatric nutritional risk index and decoy receptor 3 predicts mortality in chronic hemodialysis patients.
Tsai MT; Hu FH; Lien TJ; Chen PJ; Huang TP; Tarng DC
Am J Nephrol; 2014; 40(3):191-9. PubMed ID: 25323840
[TBL] [Abstract][Full Text] [Related]
9. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
10. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
[TBL] [Abstract][Full Text] [Related]
11. Associations of adiponectin and leptin levels with protein-energy wasting, in end stage renal disease patients.
Markaki A; Grammatikopoulou MG; Venihaki M; Kyriazis J; Perakis K; Stylianou K
Endocrinol Nutr; 2016 Nov; 63(9):449-457. PubMed ID: 27638461
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
Tripepi G; Mattace Raso F; Sijbrands E; Seck MS; Maas R; Boger R; Witteman J; Rapisarda F; Malatino L; Mallamaci F; Zoccali C
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1714-21. PubMed ID: 21642364
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
[TBL] [Abstract][Full Text] [Related]
14. Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.
Canpolat N; Sever L; Agbas A; Tasdemir M; Oruc C; Ekmekci OB; Caliskan S
Pediatr Nephrol; 2018 Nov; 33(11):2113-2122. PubMed ID: 29980850
[TBL] [Abstract][Full Text] [Related]
15. Association of leptin with mortality in patients on maintenance hemodialysis: a prospective study.
Bian X; Liu N; Bai Y; Zheng L; He P; Su X; Du F; Yang X; Li D
Iran J Kidney Dis; 2014 Jul; 8(4):314-20. PubMed ID: 25001138
[TBL] [Abstract][Full Text] [Related]
16. Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.
Yuan J; Watanabe M; Suliman M; Qureshi AR; Axelsson J; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Feb; 30(2):274-82. PubMed ID: 23975839
[TBL] [Abstract][Full Text] [Related]
17. Relationship between leptin and all-cause and cardiovascular mortality in chronic hemodialysis patients.
Díez JJ; Bossola M; Fernández-Reyes MJ; Di Stasio E; Tazza L; Luciani G; Codoceo R; Iglesias P; Rodríguez A; González E; Selgas R
Nefrologia; 2011; 31(2):206-12. PubMed ID: 21461015
[TBL] [Abstract][Full Text] [Related]
18. Age modifies the association between serum obestatin, appetite and nutritional status in maintenance hemodialysis patients.
Katkov A; Sinuani I; Azar A; Shapiro G; Efrati S; Beberashvili I
Eur J Clin Nutr; 2018 Jul; 72(7):1007-1018. PubMed ID: 29362457
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
[TBL] [Abstract][Full Text] [Related]
20. Protein-energy wasting, as well as overweight and obesity, is a long-term risk factor for mortality in chronic hemodialysis patients.
Segall L; Moscalu M; Hogaş S; Mititiuc I; Nistor I; Veisa G; Covic A
Int Urol Nephrol; 2014 Mar; 46(3):615-21. PubMed ID: 24474221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
